Vascular Malformations

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Cardiovascular Diseases

Narrower: Arteriovenous Malformations 1, Telangiectasia, Hereditary Hemorrhagic 2

Treatments and conditions

Vascular Malformations
Treatment and conditionWhere it standsTrials
DIAG723 for telangiectasia, hereditary hemorrhagicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nintedanib for telangiectasia, hereditary hemorrhagicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sirolimus for arteriovenous malformationsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zovegalisib for vascular malformationsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.